文献速递泌尿系感染泌尿系结石

弥合知识差距:输尿管支架抗生素使用的过去、现在与未来

Bridging the knowledge gap: past, present and future of antibiotic use for ureteral stents.
PubMed 文献 · BJU Int · 2024-09-04

本文通过文献综述评估输尿管支架相关感染、抗生素使用及细菌定植的现有文献,检索1983年至2024年1月的英文文献。结果发现全球缺乏支架置入、更换或拔除的抗生素预防指南,支架留置期间抗生素预防对预防尿路感染无优势,且无强证据支持拔除时使用抗生素。作者强调不必要的抗生素使用会促进细菌耐药,亟需进一步研究以制定明确指南。

要点

  • 全球缺乏输尿管支架置入、更换或拔除的抗生素预防指南。
  • 术前尿培养阴性行输尿管镜及支架置入者,可考虑仅对有风险因素者预防。
  • 支架留置期间抗生素预防对预防尿路感染无优势,拔除时无强证据支持使用。

核心结论

  • 泌尿外科医生应意识到不必要的抗生素使用会促进细菌耐药,亟需进一步研究以制定明确指南。

研究设计与样本

  • 文献综述,检索PubMed、Cochrane及泌尿协会网站,纳入1983年至2024年1月发表的英文文献。

主要发现

  • 全球缺乏输尿管支架置入、更换或拔除的抗生素预防指南。
  • 术前尿培养阴性的输尿管镜及支架置入患者,可考虑仅在有风险因素时给予预防。
  • 已置支架患者术前尿培养对指导内镜泌尿外科手术期间预防重要。
  • 支架留置期间抗生素预防对预防尿路感染无优势。
  • 无强证据支持支架拔除时使用抗生素;支架相关尿路感染治疗策略差异大。

关键数值与推荐

  • 术前尿培养阴性行输尿管镜及支架置入者,可考虑仅在有风险因素时预防。
  • 已置支架患者术前尿培养重要,以指导内镜泌尿外科手术期间预防。
  • 支架留置期间抗生素预防对预防尿路感染无优势。
  • 无强证据支持支架拔除时使用抗生素。
  • 可考虑更换支架以去除生物膜这一潜在细菌来源;支架培养可帮助指导感染治疗,因尿培养与支架培养可能不同。

临床怎么用

  • 术前尿培养阴性行输尿管镜及支架置入者,可考虑仅对有风险因素者预防。
  • 已置支架患者术前应行尿培养以指导内镜手术期间预防。
  • 支架留置期间不推荐常规抗生素预防以预防尿路感染。
  • 支架拔除时无强证据支持使用抗生素。
  • 感染时可考虑更换支架以去除生物膜,并可行支架培养指导治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the available literature on ureteric stent-related infections, the use of antibiotics and bacterial colonisation to identify the current incidence of stent-related infections, unveil knowledge gaps and generate potential hypotheses for future research. METHODS: A literature review was conducted using PubMed, Cochrane and urological association websites identifying relevant English literature published between 1983 and January 2024. RESULTS: There is a worldwide lack of guidelines for antibiotic prophylaxis for stent placement, exchange or extraction. In patients with a negative preoperative urine culture undergoing ureteroscopy and stent placement, it may be considered to only provide prophylaxis in presence of risk factors. However, in pre-stented patients a preoperative urine culture is important to guide prophylaxis during endourological surgery. During stent indwell time, antibiotic prophylaxis does not show any advantage in preventing urinary tract infections (UTIs). There is no strong evidence to support the use of antibiotics at time of stent removal. In the absence of any clear evidence, management strategies for treating UTIs in patients with ureteric stents vary widely. Stent exchange could be considered to remove the biofilm as a potential source of bacteria. Stent culture can help to guide treatment during infection as urine culture and stent culture can differ. CONCLUSION: In terms of good antibiotic stewardship, urologists should be aware that unnecessary use of antibiotics provokes bacterial resistance. There is a great need for further research in the field of antibiotic prophylaxis and stent-related infections to develop evidence that can help shape clear guidelines for this very common urological practice.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Cornette J, Lange D, Chew BH, et al. Bridging the knowledge gap: past, present and future of antibiotic use for ureteral stents. BJU Int. 2024. PMID: 39233374. doi:10.1111/bju.16515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。